drugset / Trial / NCT05653258
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
Phase 2/3
Recruiting
160 enrolled
Cedars-Sinai Medical Center
National Institute on Aging (NIA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
All participants will undergo baseline biopsies of subcutaneous abdominal adipose tissue for cellular/molecular profiling via snRNA-seq and metabolic/physiological assessments (insulin sensitivity, glucose tolerance, and β-cell function). Older obese participants will be randomized into three arms: lifestyle intervention (n=24), senolytics (n=24), or placebo (n=24).
Timeline
- Start
- 2023-10-17
- Primary completion
- 2027-02-01
- Completion
- 2028-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quercetin | Small molecule | 1000 mg | — |
| Subject | dasatinib anhydrous | Small molecule | 100 mg | — |